Abstract Supplementary Table S1 Continuous Glucose Monitoring (CGM) has been
demonstrated to be clinically valuable, reducing risks of hypoglycemia and hyperglycemia …

Background Pregnant women with type 1 diabetes are a high-risk population who are
recommended to strive for optimal glucose control, but neonatal outcomes attributed to …

Automated insulin delivery (AID) systems mimic an artificial pancreas via a predictive
algorithm integrated with continuous glucose monitoring (CGM) and an insulin pump …

Aims/hypothesis The aim of this prospective nationwide study was to examine antenatal
pregnancy care and pregnancy outcomes in women with type 1 and type 2 diabetes, and to …

OBJECTIVE To compare glycemic control, quality of life, and pregnancy outcomes of women
using insulin pumps and multiple daily injection therapy (MDI) during the Continuous …

The CONCEPTT trial compared real-time Continuous Glucose Monitoring (RT-CGM) to
capillary glucose monitoring in pregnant women with type 1 diabetes. We analyzed CGM …

OBJECTIVE To determine if temporal glucose profiles differed between 1) women who were
randomized to real-time continuous glucose monitoring (RT-CGM) or self-monitored blood …

Background Hybrid closed‐loop (HCL) therapy is rarely studied in pregnancy. We present
three cases of women with type 1 diabetes who used the Medtronic 670G HCL system for …

Background Self‐monitoring of blood glucose (SMBG) is recommended as a key component
of the management plan for diabetes therapy during pregnancy. No existing systematic …

Norbert Freinkel emphasized the need for “more aggressive therapy with exogenous insulin”
during type 1 diabetes (T1D) pregnancy. Recent advances in diabetes technology …